Charles Schwab Investment Management Inc Applied Molecular Transport Inc. Transaction History

Charles Schwab Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $117,653 - $326,104	-42,628 Reduced 34.89%	79,551 $232,000
Q1 2022 May 13, 2022	SELL	$5.63 - $13.88 $74,118 - $182,730	-13,165 Reduced 9.73%	122,179 $919,000
Q4 2021 Feb 11, 2022	BUY	$13.23 - $26.05 $19,792 - $38,970	1,496 Added 1.12%	135,344 $1.89 Million
Q3 2021 Nov 16, 2021	SELL	$25.87 - $46.61 $84,232 - $151,762	-3,256 Reduced 2.37%	133,848 $3.46 Million
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $907,243 - $1.47 Million	22,818 Added 19.97%	137,104 $6.27 Million
Q1 2021 May 17, 2021	BUY	$30.5 - $74.14 $761,158 - $1.85 Million	24,956 Added 27.94%	114,286 $5.03 Million
Q4 2020 Feb 16, 2021	SELL	$29.39 - $35.0 $3,908 - $4,655	-133 Reduced 0.15%	89,330 $2.75 Million
Q3 2020 Nov 13, 2020	BUY	$20.49 - $33.58 $1.83 Million - $3 Million	89,463 New	89,463 $2.85 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.